Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank43
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-22.93M
↓ 39% vs avg
Percentile
P43
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-16.45M
Historical baseline
PeriodValueYoY Change
TTM$-22.93M+25.6%
2024$-30.80M+22.0%
2023$-39.50M-62.5%
2022$-24.31M-140.6%
2021$-10.10M-315.0%
2020$-2.43M-546.0%
2019$-376860.00+66.4%
2018$-1.12M-